Forget 1% from a Cash ISA: I’d pick up 5%+ from these 2 FTSE 100 dividend shares

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver significantly higher income returns than a Cash ISA in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the interest rates on Cash ISAs may have increased in the last couple of years, the average return is around 1%. That’s well below the rate of inflation, and means that savers are receiving a negative real-terms return on their cash.

By contrast, it is possible to obtain a dividend yield in excess of 5% from these two FTSE 100 shares at the present time.

Although they may experience volatility due to Brexit and the prospect of a global trade war, there is scope for capital growth in the long run. As such, now could be the right time to buy them.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) may have failed to raise its dividends per share in recent years, but the stock still has a dividend yield of around 5%. Furthermore, the changes it is making to its business model could improve its long-term earnings growth outlook. This may mean that it is able to raise dividends at a brisk pace.

The company’s decision to offload a number of its consumer healthcare brands in order to focus on its pharmaceutical operations could provide it with greater focus in what is expected to be a growing industry. An ageing world population, growth in the size of the world’s population and urbanisation are expected to lead to increasing demand across the pharmaceutical industry. This could catalyse the company’s financial prospects and increase its ability to pay a higher dividend.

Since GlaxoSmithKline’s financial performance is less correlated to the wider economy than many of its FTSE 100 peers, it could provide a degree of stability during what may prove to be a volatile period for the world economy. As a result, it may deliver capital growth alongside an impressive income stream.

Sainsbury’s

While GlaxoSmithKline may offer defensive appeal, Sainsbury’s (LSE: SBRY) faces an uncertain future. The retailer’s share price has declined by 44% in the last year, with investors apparently concerned about its prospects following the collapse of its proposed merger with Asda.

Although the supermarket sector is experiencing pressure from increasingly price-conscious consumers, the threat of no-frills operators such as Aldi and Lidl and technological change, Sainsbury’s could deliver a relatively appealing income return. The company has a dividend yield of around 6% from a shareholder payout which is covered 1.9 times by profit. And, with the company’s bottom line due to rise by 4% this year, dividend growth may even be on the agenda.

Certainly, Sainsbury’s could continue its recent share price decline. With a price-to-earnings (P/E) ratio of just 8.5, however, the stock appears to have a wide margin of safety. This could mean that it is able to provide capital growth through a stock price recovery alongside its income return. This could lead to a significantly higher total return when compared to the 1% offered on average by Cash ISAs.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Modern apartments on both side of river Irwell passing through Manchester city centre, UK.
Investing Articles

With an empty ISA today, how long would it take to aim for a million?

Is it realistic to aim for a million with an empty ISA? Our writer turns from fantasy to facts to…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

What on earth’s going on with the Helium One share price?

The Helium One share price rally has stalled. Our writer reflects on the reasons and asks whether now could be…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Getting started with investing? Here are 3 UK stocks to take a look at

The next time the stock market opens, it will be the new financial year. And Stephen Wright has three UK…

Read more »

Diverse children studying outdoors
Growth Shares

2 growth shares beating Rolls-Royce stock so far this year

Jon Smith points out some growth shares that have come out of the blocks strongly in 2026, with momentum right…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

How much would someone need in an ISA to double the state pension and target a £24,436 annual income?

A full state pension is £230.25 per week. But James Beard reckons it’s possible to aim to double this by…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

New to investing? Here’s how to use the stock market to try and generate a second income

Is investing in the stock market a better way of earning a second income than starting a business? Stephen Wright…

Read more »

UK supporters with flag
Investing Articles

How much would someone need in a Stocks and Shares ISA to target a £1,667 monthly second income?

Our writer reckons a Stocks and Shares ISA is a great way of targeting a healthy second income. And it…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

April stocks: 2 value shares I’m taking a closer look at

Value investors looking for shares to buy in April have a lot of eye-catching opportunities. Here are two that I…

Read more »